Bright Minds Biosciences DRUG
NASDAQ DRUG
$23.45 +0.84 (+3.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Bright Minds Biosciences (DRUG) Other financing activities (as filed) (2021 - 2026)

Updated

Bright Minds Biosciences' Other financing activities was -$10.79 million in fiscal Q2 2026 (quarter ended Mar 31, 2026).

Analysis

Bright Minds Biosciences (DRUG) Other financing activities (as filed) (2021 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Other financing activities at Bright Minds Biosciences came in at -$257,675.

  • In earlier fiscal years, Other financing activities was -$20,008 in FY2023, $204,173 in FY2022 (-11.1%) and $229,702 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Bright Minds Biosciences 172.65 Mn -390.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.79 Mn
Dec 31, 2025 -384,445.02
Sep 30, 2025 -273,627.49
Dec 31, 2024 -59,930.89
Sep 30, 2023 -64,233.56
Dec 31, 2022 -19,873.30
Sep 30, 2021 22.06 Mn
Jun 30, 2021 -19,037.35
API Access

Bright Minds Biosciences Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=DRUG&period=max&api_key=YOUR_API_KEY